Faten N. Aberra, M.D., M.S.C.E.
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Chair, GI EPIC committee
Faculty Fellow
Chair, Women in GI Committee
Co-Director, IBD Program, Type II Center for Digestive, Liver and Pancreatic Medicine (Penn-CHOP)
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
3 Ravdin
3400 Spruce Street
Philadelphia, PA 19104
3 Ravdin
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-615-4951
Fax: 215-662-6530
Fax: 215-662-6530
Email:
faten.aberra@uphs.upenn.edu
faten.aberra@uphs.upenn.edu
Publications
Education:
BA (Biochemistry)
Swarthmore College, 1993.
MD
Dartmouth Medical School, 1997.
MSCE
University of Pennsylvania, 2004.
BA (Biochemistry)
Swarthmore College, 1993.
MD
Dartmouth Medical School, 1997.
MSCE
University of Pennsylvania, 2004.
Post-Graduate Training
Internship in Internal Medicine, Hospital of the University of Pennsylvania, 1997-1998.
Residency in Internal Medicine, Hospital of the University of Pennsylvania, 1998-2000.
Fellowship in Gastroenterology, Hospital of the University of Pennsylvania, 2000-2003.
Permanent linkInternship in Internal Medicine, Hospital of the University of Pennsylvania, 1997-1998.
Residency in Internal Medicine, Hospital of the University of Pennsylvania, 1998-2000.
Fellowship in Gastroenterology, Hospital of the University of Pennsylvania, 2000-2003.
Selected Publications
Aberra, F.A., Stettler, N, Brensinger C, Lichtenstein G.R., Lewis, J.D: Risk for Active Tuberculosis in Inflammatory Bowel Disease Patients. Clinical Gastroenterology and Hepatology 5(9): 1070-5, Sept 2007.Aberra F., Lichtenstein G.R.: Infliximab in Ulcerative Colitis. Gastroenterology Clinics of North America. Gastroenterology Clinics of North America 35(4): 821-836, Dec 2006.
Aberra, F: To be or not to be with infliximab during pregnancy? Inflammatory Bowel Diseases 12(1): 76-78, 2006.
Aberra, F.A. , Brensinger, C. M., Bilker, W.B., Lichtenstein, G.R., Lewis, J.D: Antibiotic Use and the Risk of Flare of Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 3(5): 459-465, 2005.
Aberra, F.A., Lewis, J.D., Haas, D, Rombeau J.L., Osborne, B, Lichtenstein, G.R: Preoperative Use of Azathioprine, 6-Mercaptopurine, or Corticosteroids and Risk for Postoperative Infectious Complications in Inflammatory Bowel Disease Patients Having Elective Bowel Surgery. Gastroenterology 125(2): 320-327, 2003.
